EMN Secures Series A Funding to Transform Surgical Nutrition Solutions

Enhanced Medical Nutrition, Inc. (EMN), a Toronto-based food-as-medicine company, recently announced a successful $5 million over-subscribed Series A financing round aimed at scaling its innovative medical nutrition product, ENROUTE®. This funding, led by dsm-firmenich Venturing and Ajinomoto Co., Inc., with participation from PeakBridge, Elder Ventures, and various angel investors, will enable EMN to expand its operations throughout North America.

EMN focuses on the critical role of nutrition in improving surgical outcomes, with ENROUTE® designed specifically for patients preparing for and recovering from surgery. The program addresses the nutritional requirements of these patients, aiming to reduce risks, accelerate recovery times, and enhance overall patient experiences. CEO and Co-Founder Eric Zimmerman highlighted the existing gap in tailored nutritional solutions for surgical patients and expressed excitement about the partnerships formed through this funding, emphasizing the importance of a collaborative effort in achieving the company’s mission.

Arpesh Mehta from dsm-firmenich Venturing recognized EMN's potential to transform surgical care standards, emphasizing the company’s commitment to scientific validation and patient-centric innovations. Similarly, Shunji Takehana from Ajinomoto noted the strategic partnership as a continuation of their investment in medical nutrition, aligning with their interests in nutritional supplementation for surgical patients at all stages, including prehabilitation, rehabilitation, and healthy aging.

PeakBridge’s Chief Technology Officer, Gali Artzi, echoed these sentiments, commending EMN’s approach as an essential development in a currently underserved market. The investment reflects PeakBridge’s commitment to innovative food-as-medicine solutions that improve patient outcomes and advance healthcare nutrition.

EMN’s ENROUTE® program is characterized by its proprietary, evidence-based approach tailored to the dietary management surrounding surgical procedures. It aims to overcome the typical neglect of nutrition within standard surgical care by providing targeted nutrients that address the specific metabolic and physiological requirements of surgical patients. This includes support for muscle mass, tissue repair, and immune functions, thereby facilitating the healing process pre- and post-surgery. The program is integrated into surgical protocols, allowing healthcare providers to incorporate it seamlessly into patient care.

Developed through rigorous research and testing, ENROUTE® utilizes patented technology licensed from academic institutions and is backed by clinical evidence that supports its efficacy and safety standards. Currently, it focuses on adult patients, particularly in the orthopedic surgery demographic.

The emerging domain of food-as-medicine is seen as the future of healthcare, providing proactive solutions for preventing and treating various health conditions through medical foods, functional foods, and tailored meal plans.

Enhanced Medical Nutrition is now positioned to redefine the integration of nutrition into healthcare practices, specifically in surgical settings, by leveraging innovative solutions to enhance patient care and recovery.

For more information about EMN and its products, visit www.getenroute.com.